ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $67,638,000 | +456.8% | 601,066 | +371.4% | 0.85% | +397.1% |
Q2 2020 | $12,147,000 | -47.5% | 127,500 | -50.5% | 0.17% | -56.0% |
Q1 2020 | $23,146,000 | +306.1% | 257,549 | +139.6% | 0.39% | +380.2% |
Q4 2019 | $5,700,000 | -2.3% | 107,500 | -37.4% | 0.08% | +17.4% |
Q2 2014 | $5,836,000 | -90.9% | 171,800 | -90.8% | 0.07% | -91.3% |
Q1 2014 | $64,439,000 | -23.2% | 1,867,800 | -11.8% | 0.79% | -35.7% |
Q4 2013 | $83,859,000 | – | 2,117,648 | – | 1.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |